BMS-564929 Uses, Dosage, Side Effects and more
BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
| Trade Name | BMS-564929 |
| Generic | BMS-564929 |
| Type | |
| Formula | C14H12ClN3O3 |
| Weight | Average: 305.716 Monoisotopic: 305.056718972 |
| Groups | Experimental |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
